[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pharmaceutical Excipients Market by Product (Organic Chemicals (Carbohyrates, Petrochemicals) inorganic chemicals), Functionality (Fillers, Diluents, Coatings, Disintegrants), Formulation (Tablet, Capsule, Topical, Parenteral) - Global Forecast to 2025

June 2019 | 303 pages | ID: P01C418A820EN
MarketsandMarkets

US$ 5,650.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
“Increasing growth in the pharmaceutical drug market is expected to drive the growth of the pharmaceutical excipients market.”

The pharmaceutical excipients market is projected to reach USD 9.7 billion by 2025 from USD 6.9 billion in 2019, at a CAGR of 5.8%. The growth in this market can be attributed to factors such as the growing pharmaceuticals industry coupled with advancements in functional excipients, rising adoption of orphan drugs, and increasing uptake of biopharmaceuticals. However, certain barriers, such as the increasing regulatory stringency and the cost and time-intensive drug development process are expected to restrain the growth of this market to a certain extent during the forecast period.

“Organic chemicals segment to dominate the pharmaceutical excipients market in 2019.”

Based on product, the pharmaceutical excipients market is segmented into three major categories— organic chemicals, inorganic chemicals, and other chemicals. In 2018, the organic chemicals segment accounted for the largest share of the pharmaceutical excipients market. The large share of this segment can be attributed to the use of these chemicals in the majority of pharmaceutical formulations available in the pharmaceutical market. Also, the organic chemicals market had the highest CAGR above all.

“Advantages of topical drug delivery are driving demand for excipients in this segment.”

Based on formulation, the pharmaceutical excipients market is segmented into oral, topical, parenteral, and other formulations. Currently, there is a growing focus on the use of liposomes for the delivery of topical drugs. With this, there is a growing need for developing novel excipients that can improve the solubility and functionality of such formulations. Growth in this market segment is expected to play a major role in the growth of the pharmaceutical excipients market for topical formulations in the coming years.

“Europe accounted for the largest share of the market in 2018, whereas the Asia Pacific was the fastest growing market.”

The pharmaceutical excipients market is broadly divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2018, Europe accounted for the largest share of the global pharmaceutical excipients market. The large share of this region can be attributed to the presence of a number of pharmaceutical giants with large production capacities leading to high consumption of excipients. However, the Asia Pacific region is expected to be the fastest growing market. The factors driving the growth of this region can be attributed to the increase in outsourcing of drug manufacturing to specialized contract manufacturing organizations -CMOs, rising number of companies setting up manufacturing units in these countries, favorable government regulations, low labor & manufacturing costs, and the large base for the generation of generics & biologics. The Asia Pacific market is expected to have the highest CAGR during the forecast period.

The breakup of primary participants is as mentioned below:
  • By Company Type: Tier 1 - 48%, Tier 2 - 34%, and Tier 3 - 18%
  • By Designation: C-level - 42%, Director-level - 36%, and Others - 22%
  • By Region: Europe - 38%, North America - 34%, Asia Pacific - 17%, South America -7%, and the Middle East and Africa - 4%
The prominent players in the global pharmaceutical excipients market are Ashland Global Holdings, Inc. -US, BASF SE -Germany, DuPont de Nemours, Inc. -US, Roquette -France, Evonik Industries AG -Germany, Associated British Foods -UK, Archer Daniels Midland Company -US, Lubrizol Corporation -US, and Croda International -UK. Other players in this market are Innophos Holdings -US, Kerry Group -Ireland, WACKER Chemie AG -Germany, Colorcon -US, DFE Pharma -Germany, JRS Pharma -Germany, and Air Liquide S.A -France.

Research Coverage:

The report analyzes the pharmaceutical excipients market and aims at estimating the market size and future growth potential of this market based on various segments such as product, formulation, functionality, and region. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:
  • Market Penetration: Comprehensive information on the product portfolios of the top players in the global pharmaceutical excipients market. The report analyzes this market by product, functionality, formulation, and region
  • Product Enhancement/Innovation: Detailed insights on the upcoming trends and product launches in the global pharmaceutical excipients market
  • Market Development: Comprehensive information on the lucrative emerging markets by product, functionality, formulation, and region
  • Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global pharmaceutical excipients market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of leading players in the global pharmaceutical excipients market
1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
  1.3.1 MARKETS COVERED
  1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 STAKEHOLDERS
1.6 LIMITATIONS

2 RESEARCH METHODOLOGY

2.1 RESEARCH APPROACH
  2.1.1 SECONDARY RESEARCH
    2.1.1.1 Key data from secondary sources
  2.1.2 PRIMARY RESEARCH
    2.1.2.1 Key data from primary sources
    2.1.2.2 Breakdown of Primaries
    2.1.2.3 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.3 DATA TRIANGULATION APPROACH
2.4 MARKET SHARE ESTIMATION
2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PHARMACEUTICAL EXCIPIENTS: MARKET OVERVIEW
4.2 PHARMACEUTICAL EXCIPIENTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.3 REGIONAL MIX: PHARMACEUTICAL EXCIPIENTS MARKET (2019–2025)
4.4 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET SHARE, BY FORMULATION (2018)
4.5 PHARMACEUTICAL EXCIPIENTS MARKET: DEVELOPED VS. DEVELOPING MARKETS (USD MILLION)

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
  5.2.1 MARKET DRIVERS
    5.2.1.1 Growth of the pharmaceuticals market backed by functional excipients
    5.2.1.2 Surge in the generics market
    5.2.1.3 Increasing uptake of biopharmaceuticals
    5.2.1.4 Rising adoption of orphan drugs
  5.2.2 MARKET RESTRAINTS
    5.2.2.1 Cost and time-intensive drug development process
    5.2.2.2 Increasing regulatory stringency
  5.2.3 MARKET OPPORTUNITIES
    5.2.3.1 Multifunctional excipients
    5.2.3.2 Shifting focus of pharmaceutical manufacturing to emerging countries
    5.2.3.3 Growth in the biosimilars market
  5.2.4 MARKET CHALLENGES
    5.2.4.1 Safety and quality concerns
    5.2.4.2 Changing trade policies between countries

6 INDUSTRY INSIGHTS

6.1 INTRODUCTION
6.2 INDUSTRY TRENDS
  6.2.1 RISING DEMAND AND EMPHASIS ON CO-PROCESSED EXCIPIENTS
  6.2.2 IMPROVING EXCIPIENT CAPABILITIES BY USING NANOTECHNOLOGY
  6.2.3 INCREASING USE OF DIRECT COMPRESSION IN ORAL DOSAGE FORMULATIONS
  6.2.4 PHARMACEUTICAL EXCIPIENTS INFLUENCING THE COST OF PRODUCTION
6.3 REGULATORY ANALYSIS
  6.3.1 NORTH AMERICA
    6.3.1.1 US
    6.3.1.2 Canada
  6.3.2 EUROPE
  6.3.3 ASIA PACIFIC
    6.3.3.1 Japan
    6.3.3.2 China
    6.3.3.3 India

7 PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT

7.1 INTRODUCTION
7.2 ORGANIC CHEMICALS
  7.2.1 OLEOCHEMICALS
    7.2.1.1 Fatty alcohols
      7.2.1.1.1 Fatty alcohols are widely used as nonionic surfactants due to their amphipathic nature—a major driver for market growth
    7.2.1.2 Mineral stearates
      7.2.1.2.1 Market growth is due to the wide use of magnesium stearates as excipients in nutraceutical and pharmaceutical formulations
    7.2.1.3 Glycerin
      7.2.1.3.1 The extensive applications of glycerine are expected to drive growth in this market segment
    7.2.1.4 Other oleochemicals
  7.2.2 CARBOHYDRATES
    7.2.2.1 Sugars
      7.2.2.1.1 Actual sugars
        7.2.2.1.1.1 Lactose
          7.2.2.1.1.1.1 Being the most commonly used excipient in tablets and capsules, lactose captures a major share of the actual sugars market
        7.2.2.1.1.2 Sucrose
          7.2.2.1.1.2.1 Sucrose is extensively used in oral pharmaceutical formulations—a major factor driving market growth
        7.2.2.1.1.3 Dextrose (D-Glucose)
          7.2.2.1.1.3.1 Dextrose has a wide range of applications in tablets and capsules, which is a primary driver for adoption
      7.2.2.1.2 Sugar alcohols
        7.2.2.1.2.1 Mannitol
          7.2.2.1.2.1.1 Mannitol is widely used with moisture-sensitive active ingredients as it is non-hygroscopic in nature; this is a major factor driving the adoption of this product
        7.2.2.1.2.2 Sorbitol
          7.2.2.1.2.2.1 Sorbitol is one of the most widely used compression diluents for pharmaceutical formulations owing to its various advantages
        7.2.2.1.2.3 Other sugar alcohols
      7.2.2.1.3 Artificial sweeteners
        7.2.2.1.3.1 Gradual increase in utilization of artificial sweeteners due to regulatory acceptibility is expected to drive this market
    7.2.2.2 Cellulose
      7.2.2.2.1 Microcrystalline cellulose
        7.2.2.2.1.1 Its highly compressible nature makes microcrystalline cellulose the most widely used excipient in the direct compression method for tablets
      7.2.2.2.2 Cellulose ethers
        7.2.2.2.2.1 Cellulose ethers are the most widely available polymers in nature, which is a major driving factor
      7.2.2.2.3 CMC and croscarmellose sodium
        7.2.2.2.3.1 The multiple advantages of CMC and croscarmellose sodium make them the most widely used binders, glidants, anti-adherents, and suspending agents in injectable preparations
      7.2.2.2.4 Cellulose esters
        7.2.2.2.4.1 Cellulose esters enable the delivery of drugs in cellular membranes and the intracellular matrix, which increases the demand for these substances
    7.2.2.3 Starch
      7.2.2.3.1 Modified starch
        7.2.2.3.1.1 Modified starch is widely used in sustained-release tablets due to its cold-water swelling and gel barrier formation capabilities
      7.2.2.3.2 Dried starch
        7.2.2.3.2.1 Dried starch is a strong binding and coating agent, factors boosting adoption
      7.2.2.3.3 Converted starch
        7.2.2.3.3.1 Converted starch is used as a molecular encapsulation agent and offers enhanced solubility and stability for drugs
  7.2.3 PETROCHEMICALS
    7.2.3.1 Glycols
      7.2.3.1.1 Polyethylene glycol
        7.2.3.1.1.1 PEG is the excipient of choice in a large number of drug formulations due to its tunable properties and well-established safety profile
      7.2.3.1.2 Propylene glycol
        7.2.3.1.2.1 In high amounts, propylene glycol has been reported to be toxic among the pediatric population, which could be a restraining factor for market growth
    7.2.3.2 Povidones
      7.2.3.2.1 Rising demand for fast-dissolving tablets is expected to propel the market for povidones
    7.2.3.3 Mineral hydrocarbons
      7.2.3.3.1 Petrolatum
        7.2.3.3.1.1 Increasing treatment rates for psoriasis, pruritus, eczema, and acne are driving the dermatology market, which in turn is expected to drive the growth of the petrolatum market
      7.2.3.3.2 Mineral waxes
        7.2.3.3.2.1 Being non-toxic and non-irritant by nature, they are most suitable for skin and eye preparations
      7.2.3.3.3 Mineral oils
        7.2.3.3.3.1 White mineral oils are good emollients, lubricating agents, and solvents, owing to which they are widely used in ointments
    7.2.3.4 Acrylic polymers
      7.2.3.4.1 Wide use of acrylic polymers in controlled-release drug formulations to drive the growth of this market
    7.2.3.5 Other petrochemicals
  7.2.4 PROTEINS
    7.2.4.1 Rising application of proteins as carriers for microparticles and nanoparticles to drive this market
  7.2.5 OTHER ORGANIC CHEMICALS
7.3 INORGANIC CHEMICALS
  7.3.1 CALCIUM PHOSPHATE
    7.3.1.1 Chemical purity and low incompatibility with drugs aid their high usage in the pharmaceutical industry
  7.3.2 METAL OXIDES
    7.3.2.1 Availability of silicon oxides in the hydrophobic, hydrophilic, and granulated forms to aid market growth
  7.3.3 HALITES
    7.3.3.1 Increased utilization of halites in vaccines as well as controlled-release formulations is driving their demand in the market
  7.3.4 CALCIUM CARBONATE
    7.3.4.1 Properties such as short disintegration time and excellent mechanical strength for oral dosage formulations to drive the market
  7.3.5 CALCIUM SULFATE
    7.3.5.1 Calcium sulfate is a cost-effective, quality enhancing diluent for solid dosage forms
  7.3.6 OTHER INORGANIC CHEMICALS
7.4 OTHER CHEMICALS

8 PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY

8.1 INTRODUCTION
8.2 FILLERS & DILUENTS
  8.2.1 DILUENTS OFFER PROPERTIES SUCH AS IMPROVED COHESION, DIRECT COMPRESSION, AND FLOW TO THE FINAL DOSE IN TABLETS
8.3 SUSPENDING & VISCOSITY AGENTS
  8.3.1 SUSPENSIONS OFFER ADVANTAGES SUCH AS DRUG STABILITY, MASKED TASTE OF INSOLUBLE INGREDIENTS, AND PROLONGED DRUG ACTION
8.4 COATING AGENTS
  8.4.1 THE INCREASING UTILIZATION OF SUSTAINED-RELEASE FORMULATIONS IN THE PHARMACEUTICAL INDUSTRY IS DRIVING THIS MARKET SEGMENT
8.5 BINDERS
  8.5.1 BINDERS PROVIDE THE PROPERTIES OF FLUIDITY AND COMPRESSIBILITY THAT ARE ESSENTIAL FOR TABLET MANUFACTURING
8.6 FLAVORING AGENTS & SWEETENERS
  8.6.1 FLAVORING AGENTS ARE USED TO IMPROVE THE PALATABILITY OF DRUGS
8.7 DISINTEGRANTS
  8.7.1 DISINTEGRANTS ALLOW TABLETS AND CAPSULES TO PACK A POWERFUL PORTION OF MEDICATIONS IN A SMALL FORM THAT IS EASIER TO INGEST
8.8 COLORANTS
  8.8.1 COLORING AGENTS ARE USED IN HARD AND SOFT GELATIN CAPSULES, TABLETS, ORAL LIQUIDS, AND TOPICAL CREAMS
8.9 LUBRICANTS & GLIDANTS
  8.9.1 GLIDANTS IMPROVE THE FLOW PROPERTIES OF A FORMULATION BY REDUCING INTERPARTICLE FRICTION AND COHESION
8.10 PRESERVATIVES
  8.10.1 BENZYL ALCOHOL IS A WIDELY USED PRESERVATIVE IN THE PHARMACEUTICAL AND NUTRACEUTICAL INDUSTRY
8.11 EMULSIFYING AGENTS
  8.11.1 THE USE OF SOLUBILITY ENHANCEMENT EXCIPIENTS IN LIQUID DRUG FORMULATIONS HELPS INCREASE THE BIOAVAILABILITY OF THE API
8.12 OTHER FUNCTIONALITIES

9 PHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE OF FORMULATION

9.1 INTRODUCTION
9.2 ORAL FORMULATIONS
  9.2.1 TABLETS
    9.2.1.1 Tablets are the most widely used dosage forms; this is a major contributing factor to market growth
  9.2.2 CAPSULES
    9.2.2.1 Hard gelatin capsules
      9.2.2.1.1 The ease of manufacturing of hard gelatin capsules and the versatility of this dosage form are among the major factors driving the growth of the hard gelatin capsules market
    9.2.2.2 Soft gelatin capsules
      9.2.2.2.1 Stability concerns with highly water-soluble compounds and compounds susceptible to hydrolysis have been reported with the use of soft gels, which are restricting factors for market growth
  9.2.3 LIQUID FORMULATIONS
    9.2.3.1 No dissolution time and rapid absorption from stomach compare to tablet
9.3 TOPICAL FORMULATIONS
  9.3.1 ADVANTAGES OF TOPICAL DRUG DELIVERY ARE DRIVING DEMAND FOR EXCIPIENTS IN THIS SEGMENT
9.4 PARENTERAL FORMULATIONS
  9.4.1 EMERGENCE OF NEW BIOLOGICAL MOLECULES TO INCREASE THE DEMAND FOR EXCIPIENTS
9.5 OTHER FORMULATIONS

10 PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION

10.1 INTRODUCTION
10.2 EUROPE
  10.2.1 GERMANY
    10.2.1.1 Germany accounted for the largest share of the market in 2018
  10.2.2 FRANCE
    10.2.2.1 Stringent policies to support innovation pose regulatory challenges for the pharmaceutical excipients market in France
  10.2.3 UK
    10.2.3.1 Growing adoption of generics and the development of novel multi-functional co-processed excipients to drive market growth
  10.2.4 SWITZERLAND
    10.2.4.1 Large volume of pharmaceuticals produced in Switzerland provides huge potential for the utilization of pharmaceutical excipients
  10.2.5 ITALY
    10.2.5.1 Budgetary constraints and restricted healthcare spending to impede the growth of the Italian market
  10.2.6 SPAIN
    10.2.6.1 High consumption of biologics to support market growth
  10.2.7 REST OF EUROPE
10.3 NORTH AMERICA
  10.3.1 US
    10.3.1.1 The US dominates the North American market due to the increasing use of biologics and the increasing per capita pharmaceutical spending
  10.3.2 CANADA
    10.3.2.1 Strong growth of the emerging markets and slowdown in new product approvals to hamper market growth in Canada
10.4 ASIA PACIFIC
  10.4.1 JAPAN
    10.4.1.1 Rapid growth of Japan’s geriatric population will greatly drive the demand for pharmaceuticals
  10.4.2 CHINA
    10.4.2.1 Chinese government has emphasized generics and off-patent drugs
  10.4.3 INDIA
    10.4.3.1 India is a leading producer of generics
  10.4.4 SOUTH KOREA
    10.4.4.1 Thriving generic drug market to support the growth of pharmaceutical excipients market in South Korea
  10.4.5 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
  10.5.1 GROWING GERIATRIC POPULATION AND DISEASE PREVALENCE ARE DRIVING MARKET GROWTH
10.6 MIDDLE EAST AND AFRICA
  10.6.1 UNSATURATED MARKETS IN THIS REGION HAVE DRAWN THE ATTENTION OF GLOBAL PLAYERS

11 COMPETITIVE LANDSCAPE

11.1 INTRODUCTION
11.2 GEOGRAPHICAL ASSESSMENT OF MAJOR PLAYERS IN THE PHARMACEUTICAL EXCIPIENTS MARKET
11.3 COMPETITIVE LEADERSHIP MAPPING
  11.3.1 VISIONARY LEADERS
  11.3.2 INNOVATORS
  11.3.3 DYNAMIC DIFFERENTIATORS
  11.3.4 EMERGING COMPANIES
11.4 MARKET SHARE ANALYSIS
  11.4.1 PHARMACEUTICAL EXCIPIENTS MARKET SHARE ANALYSIS, 2018
11.5 COMPETITIVE ASSESSMENT OF R&D EXPENDITURE
11.6 COMPETITIVE SITUATIONS AND TRENDS

12 COMPANY PROFILES

(Business overview, Products offered, Recent developments, MNM view, SWOT analysis)*
12.1 DUPONT DE NEMOURS, INC.
12.2 ROQUETTE FRÈRES
12.3 ASHLAND GLOBAL HOLDINGS INC.
12.4 EVONIK INDUSTRIES AG
12.5 BASF SE
12.6 KERRY GROUP PLC
12.7 CRODA INTERNATIONAL
12.8 ASSOCIATED BRITISH FOODS PLC
12.9 ARCHER DANIELS MIDLAND COMPANY
12.10 LUBRIZOL CORPORATION
12.11 INNOPHOS HOLDINGS INC.
12.12 WACKER CHEMIE AG
12.13 AIR LIQUIDE S.A.
12.14 COLORCON INC.
12.15 DMV-FONTERRA EXCIPIENTS GMBH & CO. KG
12.16 JRS PHARMA GMBH & CO. KG
*Business overview, Products offered, Recent developments, MNM view, SWOT analysis might not be captured in case of unlisted companies.

13 APPENDIX

13.1 INSIGHTS OF INDUSTRY EXPERTS
13.2 MARKET SIZING & VALIDATION APPROACH
13.3 DISCUSSION GUIDE
13.4 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.5 AVAILABLE CUSTOMIZATIONS
13.6 RELATED REPORTS
13.7 AUTHOR DETAILS

LIST OF TABLES

TABLE 1 DRUGS COMING OFF-PATENT
TABLE 2 KEY MARKET DRIVERS: IMPACT ANALYSIS
TABLE 3 KEY MARKET RESTRAINTS: IMPACT ANALYSIS
TABLE 4 MULTIFUNCTIONAL EXCIPIENTS
TABLE 5 CLINICAL STUDIES FOR BIOLOGICS & BIOSIMILARS (2017)
TABLE 6 KEY MARKET OPPORTUNITIES: IMPACT ANALYSIS
TABLE 7 KEY MARKET CHALLENGES: IMPACT ANALYSIS
TABLE 8 MARKETED CO-PROCESSED EXCIPIENTS
TABLE 9 PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2017–2025 (USD MILLION)
TABLE 10 PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 11 ORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 12 ORGANIC CHEMICALS MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 13 OLEOCHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 14 OLEOCHEMICALS MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 15 OLEOCHEMICALS: KEY BRANDS
TABLE 16 FATTY ALCOHOLS MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 17 MINERAL STEARATES MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 18 GLYCERIN MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 19 OTHER OLEOCHEMICALS MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 20 CARBOHYDRATES MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 21 CARBOHYDRATES MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 22 CARBOHYDRATES: KEY BRANDS
TABLE 23 SUGARS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 24 SUGARS MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 25 ACTUAL SUGARS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 26 ACTUAL SUGARS MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 27 SUGAR ALCOHOLS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 28 SUGAR ALCOHOLS MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 29 ARTIFICIAL SWEETENERS MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 30 CELLULOSE MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 31 CELLULOSE MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 32 MICROCRYSTALLINE CELLULOSE MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 33 CELLULOSE ETHERS MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 34 CMC & CROSCARMELLOSE SODIUM MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 35 CELLULOSE ESTERS MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 36 STARCH MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 37 STARCH MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 38 MODIFIED STARCH MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 39 DRIED STARCH MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 40 CONVERTED STARCH MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 41 PETROCHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 42 PETROCHEMICALS MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 43 PETROCHEMICALS: KEY BRANDS
TABLE 44 GLYCOLS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 45 GLYCOLS MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 46 POVIDONES MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 47 MINERAL HYDROCARBONS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 48 MINERAL HYDROCARBONS MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 49 ACRYLIC POLYMERS MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 50 OTHER PETROCHEMICALS MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 51 PROTEINS MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 52 PROTEINS: KEY BRANDS
TABLE 53 OTHER ORGANIC CHEMICALS MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 54 OTHER ORGANIC CHEMICALS: KEY BRANDS
TABLE 55 INORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 56 INORGANIC CHEMICALS MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 57 INORGANIC CHEMICALS: KEY BRANDS
TABLE 58 CALCIUM PHOSPHATE MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 59 METAL OXIDES MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 60 HALITES MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 61 CALCIUM CARBONATE MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 62 CALCIUM SULFATE MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 63 OTHER INORGANIC CHEMICALS MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 64 OTHER CHEMICALS MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 65 OTHER CHEMICALS: KEY BRANDS
TABLE 66 PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017–2025 (USD MILLION)
TABLE 67 PHARMACEUTICAL EXCIPIENTS MARKET FOR FILLERS & DILUENTS, BY COUNTRY/REGION, 2017–2025 (USD MILLION)
TABLE 68 EXCIPIENTS FOR FILLERS AND DILUENTS
TABLE 69 PHARMACEUTICAL EXCIPIENTS MARKET FOR SUSPENDING & VISCOSITY AGENTS, BY COUNTRY/REGION, 2017–2025 (USD MILLION)
TABLE 70 EXCIPIENTS FOR SUSPENDING AND VISCOSITY AGENTS
TABLE 71 PHARMACEUTICAL EXCIPIENTS MARKET FOR COATING AGENTS, BY COUNTRY/REGION, 2017–2025 (USD MILLION)
TABLE 72 EXCIPIENTS FOR COATING AGENTS
TABLE 73 PHARMACEUTICAL EXCIPIENTS MARKET FOR BINDERS, BY COUNTRY/REGION, 2017–2025 (USD MILLION)
TABLE 74 EXCIPIENTS FOR BINDERS
TABLE 75 PHARMACEUTICAL EXCIPIENTS MARKET FOR FLAVORING AGENTS & SWEETENERS, BY COUNTRY/REGION, 2017–2025 (USD MILLION)
TABLE 76 EXCIPIENTS FOR FLAVORING AGENTS
TABLE 77 PHARMACEUTICAL EXCIPIENTS MARKET FOR DISINTEGRANTS, BY COUNTRY/REGION, 2017–2025 (USD MILLION)
TABLE 78 EXCIPIENTS FOR DISINTEGRANTS
TABLE 79 PHARMACEUTICAL EXCIPIENTS MARKET FOR COLORANTS, BY COUNTRY/REGION, 2017–2025 (USD MILLION)
TABLE 80 EXCIPIENTS FOR COLORANTS
TABLE 81 PHARMACEUTICAL EXCIPIENTS MARKET FOR LUBRICANTS & GLIDANTS, BY COUNTRY/REGION, 2017–2025 (USD MILLION)
TABLE 82 EXCIPIENTS FOR LUBRICANTS AND GLIDANTS
TABLE 83 PHARMACEUTICAL EXCIPIENTS MARKET FOR PRESERVATIVES, BY COUNTRY/REGION, 2017–2025 (USD MILLION)
TABLE 84 EXCIPIENTS FOR PRESERVATIVES
TABLE 85 PHARMACEUTICAL EXCIPIENTS MARKET FOR EMULSIFYING AGENTS, BY COUNTRY/REGION, 2017–2025 (USD MILLION)
TABLE 86 EXCIPIENTS FOR EMULSIFYING AGENTS
TABLE 87 OTHER FUNCTIONALITIES MARKET, BY COUNTRY/REGION, 2017–2025 (USD MILLION)
TABLE 88 EXCIPIENTS FOR OTHER FUNCTIONALITIES
TABLE 89 PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2017–2025 (USD MILLION)
TABLE 90 EXCIPIENTS FOR ORAL FORMULATIONS
TABLE 91 PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2017–2025 (USD MILLION)
TABLE 92 PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 93 TYPICAL COMPOSITION OF TABLETS
TABLE 94 PHARMACEUTICAL EXCIPIENTS MARKET FOR TABLETS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 95 PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2017–2025 (USD MILLION)
TABLE 96 PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 97 PHARMACEUTICAL EXCIPIENTS MARKET FOR HARD GELATIN CAPSULES, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 98 PHARMACEUTICAL EXCIPIENTS MARKET FOR SOFT GELATIN CAPSULES, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 99 PHARMACEUTICAL EXCIPIENTS MARKET FOR LIQUID FORMULATIONS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 100 EXCIPIENTS FOR TOPICAL FORMULATIONS
TABLE 101 PHARMACEUTICAL EXCIPIENTS MARKET FOR TOPICAL FORMULATIONS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 102 TYPICAL COMPOSITION OF PARENTERAL FORMULATIONS
TABLE 103 EXCIPIENTS USED IN PARENTERAL FORMULATIONS
TABLE 104 PHARMACEUTICAL EXCIPIENTS MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 105 PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FORMULATIONS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 106 PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2017–2025 (USD MILLION)
TABLE 107 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 108 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2017–2025 (USD MILLION)
TABLE 109 EUROPE: ORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 110 EUROPE: INORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 111 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017–2025 (USD MILLION)
TABLE 112 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, FORMULATION, 2017–2025 (USD MILLION)
TABLE 113 GERMANY: KEY MICROINDICATORS
TABLE 114 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2017–2025 (USD MILLION)
TABLE 115 GERMANY: ORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 116 GERMANY: INORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 117 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017–2025 (USD MILLION)
TABLE 118 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, FORMULATION, 2017–2025 (USD MILLION)
TABLE 119 FRANCE: KEY MICROINDICATORS
TABLE 120 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2017–2025 (USD MILLION)
TABLE 121 FRANCE: ORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 122 FRANCE: INORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 123 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017–2025 (USD MILLION)
TABLE 124 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, FORMULATION, 2017–2025 (USD MILLION)
TABLE 125 UK: KEY MICROINDICATORS
TABLE 126 UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2017–2025 (USD MILLION)
TABLE 127 UK: ORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 128 UK: INORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 129 UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017–2025 (USD MILLION)
TABLE 130 UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2017–2025 (USD MILLION)
TABLE 131 SWITZERLAND: KEY MICROINDICATORS
TABLE 132 SWITZERLAND: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2017–2025 (USD MILLION)
TABLE 133 SWITZERLAND: ORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 134 SWITZERLAND: INORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 135 SWITZERLAND: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017–2025 (USD MILLION)
TABLE 136 SWITZERLAND: PHARMACEUTICAL EXCIPIENTS MARKET, FORMULATION, 2017–2025 (USD MILLION)
TABLE 137 ITALY: KEY MICROINDICATORS
TABLE 138 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2017–2025 (USD MILLION)
TABLE 139 ITALY: ORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 140 ITALY: INORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 141 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017–2025 (USD MILLION)
TABLE 142 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, FORMULATION, 2017–2025 (USD MILLION)
TABLE 143 SPAIN: KEY MICROINDICATORS
TABLE 144 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2017–2025 (USD MILLION)
TABLE 145 SPAIN: ORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 146 SPAIN: INORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 147 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017–2025 (USD MILLION)
TABLE 148 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2017–2025 (USD MILLION)
TABLE 149 ROE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2017–2025 (USD MILLION)
TABLE 150 ROE: ORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 151 ROE: INORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 152 ROE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017–2025 (USD MILLION)
TABLE 153 ROE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2017–2025 (USD MILLION)
TABLE 154 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 155 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2017–2025 (USD MILLION)
TABLE 156 NORTH AMERICA: ORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 157 NORTH AMERICA: INORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 158 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017–2025 (USD MILLION)
TABLE 159 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2017–2025 (USD MILLION)
TABLE 160 US: KEY MICROINDICATORS
TABLE 161 US: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2017–2025 (USD MILLION)
TABLE 162 US: ORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 163 US: INORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 164 US: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017–2025 (USD MILLION)
TABLE 165 US: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2017–2025 (USD MILLION)
TABLE 166 CANADA: KEY MICROINDICATORS
TABLE 167 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2017–2025 (USD MILLION)
TABLE 168 CANADA: ORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 169 CANADA: INORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 170 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017–2025 (USD MILLION)
TABLE 171 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2017–2025 (USD MILLION)
TABLE 172 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 173 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2017–2025 (USD MILLION)
TABLE 174 ASIA PACIFIC: ORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 175 ASIA PACIFIC: INORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 176 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017–2025 (USD MILLION)
TABLE 177 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2017–2025 (USD MILLION)
TABLE 178 JAPAN: KEY MICROINDICATORS
TABLE 179 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2017–2025 (USD MILLION)
TABLE 180 JAPAN: ORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 181 JAPAN: INORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 182 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017–2025 (USD MILLION)
TABLE 183 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2017–2025 (USD MILLION)
TABLE 184 CHINA: KEY MICROINDICATORS
TABLE 185 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2017–2025 (USD MILLION)
TABLE 186 CHINA: ORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 187 CHINA: INORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 188 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017–2025 (USD MILLION)
TABLE 189 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2017–2025 (USD MILLION)
TABLE 190 INDIA: KEY MICROINDICATORS
TABLE 191 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2017–2025 (USD MILLION)
TABLE 192 INDIA: ORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 193 INDIA: INORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 194 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017–2025 (USD MILLION)
TABLE 195 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2017–2025 (USD MILLION)
TABLE 196 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2017–2025 (USD MILLION)
TABLE 197 SOUTH KOREA: ORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 198 SOUTH KOREA: INORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 199 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017–2025 (USD MILLION)
TABLE 200 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2017–2025 (USD MILLION)
TABLE 201 ROAPAC: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2017–2025 (USD MILLION)
TABLE 202 ROAPAC: ORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 203 ROAPAC: INORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 204 ROAPAC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017–2025 (USD MILLION)
TABLE 205 ROAPAC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2017–2025 (USD MILLION)
TABLE 206 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2017–2025 (USD MILLION)
TABLE 207 LATIN AMERICA: ORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 208 LATIN AMERICA: INORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 209 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017–2025 (USD MILLION)
TABLE 210 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2017–2025 (USD MILLION)
TABLE 211 MIDDLE EAST AND AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2017–2025 (USD MILLION)
TABLE 212 MIDDLE EAST AND AFRICA: ORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 213 MIDDLE EAST AND AFRICA: INORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION)
TABLE 214 MIDDLE EAST AND AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017–2025 (USD MILLION)
TABLE 215 MIDDLE EAST AND AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2017–2025 (USD MILLION)
TABLE 216 PRODUCT LAUNCHES (2018-2019)
TABLE 217 MERGERS AND ACQUISITIONS (2017-2019)
TABLE 218 AGREEMENTS AND PARTNERSHIPS (2018-2019)
TABLE 219 EXPANSIONS (2018-2019)
TABLE 220 OTHER DEVELOPMENTS (2016-2018)

The global pharmaceutical excipients market is estimated to be valued at $XX million in 2013 and is expected to reach $XX million by 2018, growing at a CAGR of XX% from 2013 to 2018. The market is highly fragmented with numerous players and is commoditized to an extent. In 2012, none of the market players had market shares worth more than XX%. Some of the leading players in the industry include BASF (Germany), Ashland, Inc. (U.S.), Dow Chemical Company (U.S.), FMC (U.S.), Roquette (France), JRS Pharma (Germany), and Associated British Foods (U.K.). Together, the top 10 players accounted for approximately XX% to XX% of the global pharmaceutical excipients market in 2012. The smaller players—based in emerging markets such as China, India, or Brazil—together hold a significant share of the market.

Currently, the global pharmaceutical excipients industry is driven by the rising demand for functional excipients from the pharmaceutical industry. This increase in demand can be attributed to the need to address the solubility issues of the recently developed APIs. Development of multifunctional excipients and co-processed excipients is also expected to play a vital role in market growth during the forecast period. In addition, the sudden increase in the generics market due to patent expiration of many blockbuster drugs is also expected to drive the sales volume of the excipients market during the forecast period.

As pharmaceutical excipients form a miniscule fraction of the overall pharmaceutical industry and individual excipient ingredients market as well, most pharmaceutical excipients manufacturers did not adhere to the stringent quality and regulatory requirements for their pharmaceutical applications. However, more recent quality issues with excipients have led to strict regulatory guidelines for use of excipients in the pharmaceutical industry. Today, quality and safety regulations extend to deeper levels of the industry starting from designing of excipients to manufacturing, supply chain, and storage. This has impacted the smaller businesses in the industry, wherein non-compliance has resulted in severe economic losses for these players.

Currently, the global healthcare scenario is under transition with rising concerns for healthcare cost control. Thus, many of the pharmaceutical companies are under pressure to maintain their existing profit margins and improve them in future. This has led to a dramatic shift in the business model of some of the leading pharmaceutical manufacturers in the industry. As a direct impact of this, excipient manufacturers are under enormous pressure to cut prices. Furthermore, the increasing cost of raw materials, stringent regulatory requirements and quality specifications, and the increasingly competitive environment are all factors that are leading to the rapid erosion of profit margins for many of the excipient manufacturers. Declining R&D investments from excipient manufacturers also represent a significant challenge for the market growth during the forecast period of 2013 to 2018.

The global pharmaceutical excipients market studied in this report is segmented in two ways, namely, by functionality and by products.

The overall pharmaceutical excipients market can be segmented under the categories, by product and by functionality markets. The by product type market is further divided into three categories, namely organic chemicals, inorganic chemicals, and others. The by functionality market is divided into ten categories, namely fillers & diluents, binders, suspension & viscosity agents, coatings, flavoring agents, disintegrants, colorants, lubricants & glidants, preservatives, and other applications.



More Publications